AI and Computer Vision-Assisted Telerehabilitation in Fibromyalgia: The FibroIA 2.0 Trial

Fibromyalgia (FM) is a primary chronic pain condition with an estimated prevalence of 3.3% in Chile. It is characterized by widespread musculoskeletal pain, fatigue, and impaired physical function. Although exercise therapy is considered the first-line intervention, barriers to access and poor adherence limit its effectiveness within the public healthcare system. This study evaluates the effectiveness of an Artificial Intelligence (AI)- and Computer Vision (CV)-assisted telerehabilitation platform called Rehbody. The aim is to determine whether real-time technology-driven feedback can overcome the limitations of traditional face-to-face rehabilitation models by improving disease impact and functional capacity in Chilean patients with fibromyalgia.

NCT Number	NCT07674485
Lead Sponsor	Instituto Neurociencia Del Dolor Collaborators: Universidad San Sebastián, University of Alcala
Conditions	Fibromyalgia, Fibromyalgia (FM), Fibromyalgia Syndrome
Enrollment	66 participants
Start Date	2027-01-04
Primary Completion	2027-03-28 (estimated)
Study Completion	2027-06-21 (estimated)
Updated on ClinicalTrials.gov	2026-07-01